Submitted to: Patent Application
Publication Type: Patent Application
Publication Acceptance Date: August 21, 2002
Publication Date: January 14, 2003
Citation: Beier, R.C. 2003. Monoclonal antibodies to the drug Tilmicosin and a method for detecting the same. U.S. Patent 6,506,885. Technical Abstract: Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to tilmicosin. These hybridomas may be obtained by using as an immunization agent or immunogen, 23-deoxo-23demycinosyl tilmicosin which has been conjugated to an immunogenic carrier. The antibodies may be used to detect and/or quantify tilmicosin in biological samples. The monoclonal antibodies also may be incorporated into kits.